Clinical trials
Phase 3 Lung Diseases, Interstitial trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 7 |
| Completed | 4 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 6 |
| United Therapeutics | 3 |
| GlaxoSmithKline | 2 |
| Bristol-Myers Squibb | 1 |
| Gilead Sciences | 1 |
| Insmed Incorporated | 1 |
| Kyntra Bio | 1 |
| Liquidia Technologies, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases, Interstitial | 16 |
| Idiopathic Pulmonary Fibrosis | 4 |
| Connective Tissue Diseases | 3 |
| Hypertension, Pulmonary | 2 |
| Pulmonary Fibrosis | 2 |
| Scleroderma, Diffuse | 2 |
| Arthritis, Rheumatoid | 1 |
| Autoimmune Diseases | 1 |
| Fibrosis | 1 |
| Idiopathic Interstitial Pneumonias | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.